Search Blog
Categories
October 2017
M T W T F S S
« Sep   Nov »
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Tags

Archive for October 23rd, 2017

SPF-TSX.V Launches Revised Website and New Domain Address

SPF-TSX.V Launches Revised Website and New Domain Address Vancouver, British Columbia (FSCwire) – Silver Pursuit Resources Ltd. (SPF TSX.V) is pleased to announce the launch of a revised website and the change of its domain address from www.silverpursuit.ca to www.silverpursuit.com. The new website includes the announcement of new additions to Board of Directors, management and […]

VITAMIN SHOPPE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Vitamin Shoppe, Inc. To Contact The Firm

By Faruqi & Faruqi, LLP NEW YORK, NY / ACCESSWIRE / October 23, 2017 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Vitamin Shoppe, Inc. (”Vitamin Shoppe” or the ”Company”) (NYSE: VSI) of the October 27, 2017 deadline to seek the role of lead plaintiff in a federal securities […]

TSX-V: SPF Launches Revised Website and New Domain Address

By Silver Pursuit Resources Ltd. VANCOUVER, BC / ACCESSWIRE / October 23, 2017 / Silver Pursuit Resources Ltd. (TSX-V: SPF) is pleased to announce the launch of a revised website and the change of its domain address from www.silverpursuit.ca to www.silverpursuit.com. The new website includes the announcement of new additions to Board of Directors, management, […]

Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit has been Filed Against Vitamin Shoppe, Inc. (VSI) and Encourages Investors to Contact the Firm Before October 27th

By Bragar Eagel & Squire, P.C. NEW YORK, NY / ACCESSWIRE / October 23, 2017 / Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of all persons or entities who purchased or otherwise acquired Vitamin […]

Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Health Insurance Innovations, Inc. (HIIQ) and Encourages Investors to Contact the Firm Before November 10th

By Bragar Eagel & Squire, P.C. NEW YORK, NY / ACCESSWIRE / October 23, 2017 / Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of all persons or entities who purchased or otherwise acquired […]

All Greens Is Arizona’s First State Approved Medical Marijuana Drive-Thru Dispensary

By All Greens SUN CITY, AZ / ACCESSWIRE / October 23, 2017 / All Greens has been an Arizona state licensed dispensary since 2013, relocating earlier this year from Surprise to Sun City. All Greens offers patients a variety of options when choosing their medications offering flower, concentrates, vapes, topicals, tinctures and the largest selection […]

Vitalhub Corp. Announces Private Placement & Securities for Debt Transaction

Toronto, Ontario–(Newsfile Corp. – October 23, 2017) – VITALHUB CORP. (TSXV: VHI) (the “Company” or “VitalHub“) is pleased to announce that the Company intends to complete a private placement of up to 1,500,000 (the “Offering“) of units (the “Units“) at a price of $0.10 per Unit, for total gross proceeds of up to $150,000. Each […]

Metals Creek Resources Corp. Closes First Tranche of Non-Brokered Private Placement of Flow-Through and Non Flow-Through Units

Toronto, Ontario–(Newsfile Corp. – October 23, 2017) – Metals Creek Resources Corp. (TSXV: MEK) (the “Company”) is pleased to announce that, further to a new release dated October 6, 2017, it has closed the first tranche of its previously announced non-brokered private placement (the “Placement”) for gross proceeds of $332,000, consisting of 2,650,000 flow-through units […]

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH)

By Stonegate Capital Partners DALLAS, TX / ACCESSWIRE / October 23, 2017 / Bio-Path Holdings, Inc. (NASDAQ: BPTH): COMPANY DESCRIPTION Bio-Path Holdings, Inc. (Bio-Path) is a clinical stage biotechnology company that focuses on developing nucleic acid cancer therapeutics using its proprietary nanoparticle RNAi antisense technology called DNAbilize®. This technology safely distributes nucleic acid based drugs […]

MorphoSys Receives FDA Breakthrough Therapy Designation for Its Antibody MOR208 in Relapsed/Refractory DLBCL

By MorphoSys AG Designation is Intended to Expedite Development of MorphoSys’ Most Advanced Blood Cancer Drug Candidate MOR208 in Combination with Cancer Drug Lenalidomide PLANEGG, MUNICH, GERMANY / ACCESSWIRE / October 23, 2017 / MorphoSys AG (FRA: MOR; Prime Standard Segment, TecDAX; OTC PINK: MPSYY) announced today that the U.S. Food and Drug Administration (FDA) […]